More than a bridging therapy: Targeting CD123 with rapidly switchable universal CAR-T cells for treatment of acute leukemia

被引：0

作者：

Loff, Simon ^{[1
]}

Meyer, Jan-Erik ^{[2
]}

Spehr, Johannes ^{[2
]}

Riewaldt, Julia ^{[2
]}

Gruender, Cordula ^{[1
]}

Schreiber, Maria ^{[1
]}

Bachmann, Michael ^{[3
]}

Pehl, Michael ^{[1
]}

Ehninger, Gerhard ^{[4
]}

Ehninger, Armin ^{[1
]}

Cartellieri, Marc ^{[2
]}

机构：

[1] Gemoab Monoclonals GmbH, Dresden, Germany

[2] Cellex Patient Treatment GmbH, Dresden, Germany

[3] Helmholtz Zentrum Dresden Rossendorf eV, Dresden, Germany

[4] Cellex Gesell Zellgewinnung mbH, Dresden, Germany

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-4232

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4232

引用

页数：2

共 50 条

[1] Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia
Loff, Simon
Dietrich, Josephine
Meyer, Jan-Erik
Riewaldt, Julia
Spehr, Johannes
von Bonin, Malte
Gruender, Cordula
Swayampakula, Mridula
Franke, Kristin
Feldmann, Anja
Bachmann, Michael
Ehninger, Gerhard
Ehninger, Armin
Cartellieri, Marc
MOLECULAR THERAPY-ONCOLYTICS, 2020, 17 : 408 - 420
[2] Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia
Mayumi Sugita
Roman Galetto
Hongliang Zong
Nathan Ewing-Crystal
Vicenta Trujillo-Alonso
Nuria Mencia-Trinchant
Winnie Yip
Stephanie Filipe
Celine Lebuhotel
Agnès Gouble
Duane C. Hassane
Julianne Smith
Gail J. Roboz
Monica L. Guzman
Nature Communications, 13
[3] Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia
Sugita, Mayumi
Galetto, Roman
Zong, Hongliang
Ewing-Crystal, Nathan
Trujillo-Alonso, Vicenta
Mencia-Trinchant, Nuria
Yip, Winnie
Filipe, Stephanie
Lebuhotel, Celine
Gouble, Agnes
Hassane, Duane C.
Smith, Julianne
Roboz, Gail J.
Guzman, Monica L.
NATURE COMMUNICATIONS, 2022, 13 (01)
[4] Design and in Vitro Evaluation of a CAR-T Prototype (ARI-0003) Targeting CD123 for Acute Myeloid Leukemia
Bataller Torralba, Alex
Tirado, Nestor
Sanchez-Martinez, Diego
Velasco-Hernandez, Talia
Oliver-Caldes, Aina
Castano Diez, Sandra
Guijarro, Francesca
Diaz-Beya, Marina
Juan, Manel
Engel, Pablo
Bueno, Clara
Menendez, Pablo
Urbano-Ispizua, Alvaro
Esteve, Jordi
BLOOD, 2021, 138
[5] Loop33 x 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
Ma, Haotian
Yan, Zhifeng
Gu, Runxia
Xu, Yingxi
Qiu, Shaowei
Xing, Haiyan
Tang, Kejing
Tian, Zheng
Rao, Qing
Wang, Min
Wang, Jianxiang
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 74 (01)
[6] Allogenic CAR T-Cells Targeting CD123 for Adoptive Immunotherapy of Acute Myeloid Leukemia (AML)
Galetto, Roman
Lebuhotel, Celine
Francon, Patricia
Gouble, Agnes
Smith, Julianne
MOLECULAR THERAPY, 2015, 23 : S166 - S166
[7] ALLOGENIC ADOPTIVE IMMUNOTHERAPY OF ACUTE MYELOID LEUKEMIA (AML) BY TARGETING CD123 WITH CAR T-CELLS
Galetto, R.
Lebuhotel, C.
Francon, P.
Gouble, A.
Smith, J.
HAEMATOLOGICA, 2015, 100 : 172 - 172
[8] Allogenic CAR T-Cells Targeting CD123 Effectively Eliminate Myeloid Leukemia Cells
Galetto, Roman
Lebuhotel, Celine
Gouble, Agnes
Bank, Alexander
Roboz, Gail J.
Guzman, Monica L.
Smith, Julianne
MOLECULAR THERAPY, 2016, 24 : S157 - S158
[9] CD123 CAR T cells for the treatment of myelodysplastic syndrome
Stevens, Brett M.
Zhang, Wei
Pollyea, Daniel A.
Winters, Amanda
Gutman, Jonathan
Smith, Clayton
Budde, Elizabeth
Forman, Stephen J.
Jordan, Craig T.
Purev, Enkhtsetseg
EXPERIMENTAL HEMATOLOGY, 2019, 74 : 52 - 63
[10] Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML
Wermke, Martin
Kraus, Sabrina
Ehninger, Armin
Bargou, Ralf C.
Goebeler, Maria-Elisabeth
Middeke, Jan Moritz
Kreissig, Carla
von Bonin, Malte
Koedam, Jan
Pehl, Michael
Bornhaeuser, Martin
Einsele, Hermann
Ehninger, Gerhard
Cartellieri, Marc
BLOOD, 2021, 137 (22) : 3145 - 3148

← 1 2 3 4 5 →